Ledger.Open graph →
SEC Form D · Amendment · filed May 31, 2022

Cellebration Life Sciences, Inc

Offering
$20.0M
Sold
$1.3M
Exemption
Rule 506(c)
Industry
Biotechnology
Location
PHOENIX, AZ
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (12)

Bill Deegan · Phoenix, AZDirectorDeven Patel · San Diego, CADirectorTim Kopatich · Phoenix, AZExecAnand Srivastava · San Diego, CADirectorDana Stalder · San Francisco, CAExecAnna-Lena Kamenetzky · San Francisco, CADirectorMatthew Killebrew · Dallas, TXDirectorZubin Bhettay · San Francisco, CADirectorHallbjorn Karlsson · New York, NYExecGregg Rubin · New York, NYDirectorGrace Ray · New York, NYDirectorAnthony Sciortino · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗